PROACTA
Research PROACTA (PAC.WA) on Bullrun: P/E 79.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPAC.WA
- ExchangeXNCO
- CountryPoland
- SectorCommunication Services
- IndustryAdvertising Agencies
- CurrencyPLN
- P/E79.5
- Financial periodQ2 2026
- RevenuePLN 1.51M
- Net income-PLN 166.06K
- Free cash flow-PLN 2.40M
- Gross margin131.8%
Valuation Snapshot
P/E is 79.5.
Peer valuation comparison
Latest P/E is 79.5x versus a Communication Services sector median of 16.24x (389.6% above).
Latest P/E is 79.5x versus a Poland median of 12.32x (545.5% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | n/a | 79.5 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About PROACTA
Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; Digital Breast Cancer Unit, an innovative platform using advanced technologies to optimize the breast cancer treatment process;
Related stock research
Other Communication Services stocks
Frequently asked questions
What is PROACTA's P/E ratio?
PROACTA's price-to-earnings (P/E) ratio is 79.5.
What does PROACTA do?
Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; Digital Breast Cancer Unit, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process.